BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17425505)

  • 1. Recurrent fusion oncogenes in carcinomas.
    Teixeira MR
    Crit Rev Oncog; 2006 Dec; 12(3-4):257-71. PubMed ID: 17425505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Landscape of gene fusions in epithelial cancers: seq and ye shall find.
    Kumar-Sinha C; Kalyana-Sundaram S; Chinnaiyan AM
    Genome Med; 2015 Dec; 7():129. PubMed ID: 26684754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular events in follicular thyroid tumors.
    Kroll TG
    Cancer Treat Res; 2004; 122():85-105. PubMed ID: 16209039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.
    Prasad ML; Vyas M; Horne MJ; Virk RK; Morotti R; Liu Z; Tallini G; Nikiforova MN; Christison-Lagay ER; Udelsman R; Dinauer CA; Nikiforov YE
    Cancer; 2016 Apr; 122(7):1097-107. PubMed ID: 26784937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphologic features of carcinomas with recurrent gene fusions.
    Qi M; Li Y; Liu J; Yang X; Wang L; Zhou Z; Han B
    Adv Anat Pathol; 2012 Nov; 19(6):417-24. PubMed ID: 23060067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tumor-type specific translocations methods and indications for routine molecular pathology].
    Gattenlöhner S; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 2007; 91():154-9. PubMed ID: 18314609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene.
    Behboudi A; Enlund F; Winnes M; Andrén Y; Nordkvist A; Leivo I; Flaberg E; Szekely L; Mäkitie A; Grenman R; Mark J; Stenman G
    Genes Chromosomes Cancer; 2006 May; 45(5):470-81. PubMed ID: 16444749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells.
    Pierotti MA; Bongarzone I; Borello MG; Greco A; Pilotti S; Sozzi G
    Genes Chromosomes Cancer; 1996 May; 16(1):1-14. PubMed ID: 9162191
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Bastos AU; de Jesus AC; Cerutti JM
    Eur J Endocrinol; 2018 Jan; 178(1):83-91. PubMed ID: 29046324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas.
    Skálová A; Stenman G; Simpson RHW; Hellquist H; Slouka D; Svoboda T; Bishop JA; Hunt JL; Nibu KI; Rinaldo A; Vander Poorten V; Devaney KO; Steiner P; Ferlito A
    Am J Surg Pathol; 2018 Feb; 42(2):e11-e27. PubMed ID: 29076877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas.
    Cheung L; Messina M; Gill A; Clarkson A; Learoyd D; Delbridge L; Wentworth J; Philips J; Clifton-Bligh R; Robinson BG
    J Clin Endocrinol Metab; 2003 Jan; 88(1):354-7. PubMed ID: 12519876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of 548 oncogenic fusion transcripts in thyroid tumors supports the importance of the already established thyroid fusions genes.
    Celestino R; Sigstad E; Løvf M; Thomassen GO; Grøholt KK; Jørgensen LH; Berner A; Castro P; Lothe RA; Bjøro T; Sobrinho-Simões M; Soares P; Skotheim RI
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1154-64. PubMed ID: 22961909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic causes of the thyroid carcinomas].
    Jindrichová S; Vlcek P; Bendlová B
    Cas Lek Cesk; 2004; 143(10):664-8. PubMed ID: 15584614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay.
    Argani P; Lal P; Hutchinson B; Lui MY; Reuter VE; Ladanyi M
    Am J Surg Pathol; 2003 Jun; 27(6):750-61. PubMed ID: 12766578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusion genes in solid tumors.
    Aman P
    Semin Cancer Biol; 1999 Aug; 9(4):303-18. PubMed ID: 10448117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenes and thyroid cancer.
    Vecchio G; Santoro M
    Clin Chem Lab Med; 2000 Feb; 38(2):113-6. PubMed ID: 10834397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel subtype of H4-RET rearrangement in a thyroid papillary carcinoma and lymph node metastasis.
    Giannini R; Salvatore G; Monaco C; Sferratore F; Pollina L; Pacini F; Basolo F; Fusco A; Santoro M
    Int J Oncol; 2000 Mar; 16(3):485-9. PubMed ID: 10675479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rearrangements of RET and NTRK1 tyrosine kinase receptors in papillary thyroid carcinomas.
    Pierotti MA; Vigneri P; Bongarzone I
    Recent Results Cancer Res; 1998; 154():237-47. PubMed ID: 10027004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oncogenes RET/PTC and mechanisms of their involvement in thyroid cancerogenesis].
    Voskoboĭnyk LH
    Ukr Biokhim Zh (1999); 2009; 81(6):17-25. PubMed ID: 20387655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Search for NTRK1 proto-oncogene rearrangements in human thyroid tumours originated after therapeutic radiation.
    Bounacer A; Schlumberger M; Wicker R; Du-Villard JA; Caillou B; Sarasin A; Suárez HG
    Br J Cancer; 2000 Jan; 82(2):308-14. PubMed ID: 10646882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.